These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 27111431)

  • 1. Comparison of two silica based nonviral gene therapy vectors for breast carcinoma: evaluation of the p53 delivery system in Balb/c mice.
    Rejeeth C; Vivek R
    Artif Cells Nanomed Biotechnol; 2017 May; 45(3):489-494. PubMed ID: 27111431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
    Rejeeth C; Salem A
    J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53 gene therapy of human breast carcinoma: using a transferrin-modified silica nanoparticles.
    Rejeeth C; Kannan S
    Breast Cancer; 2016 Jan; 23(1):101-110. PubMed ID: 24795076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma.
    Díez S; Navarro G; de ILarduya CT
    J Gene Med; 2009 Jan; 11(1):38-45. PubMed ID: 19021130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved gene transfer with histidine-functionalized mesoporous silica nanoparticles.
    Brevet D; Hocine O; Delalande A; Raehm L; Charnay C; Midoux P; Durand JO; Pichon C
    Int J Pharm; 2014 Aug; 471(1-2):197-205. PubMed ID: 24853464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 gene therapy of human osteosarcoma using a transferrin-modified cationic liposome.
    Nakase M; Inui M; Okumura K; Kamei T; Nakamura S; Tagawa T
    Mol Cancer Ther; 2005 Apr; 4(4):625-31. PubMed ID: 15827336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Graphene Oxide-supported APTES-Spermine, as Gene Delivery System, for Transfection of pEGFP-p53 into Breast Cancer Cell Lines.
    Mirzaie V; Ansari M; Nematollahi-Mahani SN; Moballegh Nasery M; Karimi B; Eslaminejad T; Pourshojaei Y
    Drug Des Devel Ther; 2020; 14():3087-3097. PubMed ID: 32801647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 and PTEN/MMAC1/TEP1 gene therapy of human prostate PC-3 carcinoma xenograft, using transferrin-facilitated lipofection gene delivery strategy.
    Seki M; Iwakawa J; Cheng H; Cheng PW
    Hum Gene Ther; 2002 Apr; 13(6):761-73. PubMed ID: 11936974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated p53 and ING4 gene co-transfer elicits synergistic antitumor effects through enhancement of p53 acetylation in breast cancer.
    Wu J; Zhu Y; Xu C; Xu H; Zhou X; Yang J; Xie Y; Tao M
    Oncol Rep; 2016 Jan; 35(1):243-52. PubMed ID: 26530780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising plasmid DNA vector based on APTES-modified silica nanoparticles.
    Cheang TY; Tang B; Xu AW; Chang GQ; Hu ZJ; He WL; Xing ZH; Xu JB; Wang M; Wang SM
    Int J Nanomedicine; 2012; 7():1061-7. PubMed ID: 22403488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
    Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel amino-modified silica nanoparticles as efficient vector for hepatocellular carcinoma gene therapy.
    Xiao X; He Q; Huang K
    Med Oncol; 2010 Dec; 27(4):1200-7. PubMed ID: 19949900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A silica-polymer composite nano system for tumor-targeted imaging and p53 gene therapy of lung cancer.
    Wu H; Zhao Y; Mu X; Wu H; Chen L; Liu W; Mu Y; Liu J; Wei X
    J Biomater Sci Polym Ed; 2015; 26(6):384-400. PubMed ID: 25624096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization.
    Ndoye A; Dolivet G; Høgset A; Leroux A; Fifre A; Erbacher P; Berg K; Behr JP; Guillemin F; Merlin JL
    Mol Ther; 2006 Jun; 13(6):1156-62. PubMed ID: 16564229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
    Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
    Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
    Zhao Y; Li Z; Sheng W; Miao J; Yang J
    Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nano-Hydroxyapatite-Derived Drug and Gene Co-Delivery System for Anti-Angiogenesis Therapy of Breast Cancer.
    Zhao L; Zhao W; Liu Y; Chen X; Wang Y
    Med Sci Monit; 2017 Oct; 23():4723-4732. PubMed ID: 28968380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced transfection efficiency and targeted delivery of self-assembling h-R3-dendriplexes in EGFR-overexpressing tumor cells.
    Li J; Li S; Xia S; Feng J; Zhang X; Hao Y; Chen L; Zhang X
    Oncotarget; 2015 Sep; 6(28):26177-91. PubMed ID: 26309162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of bax and p53 naked gene transfer in lung cancer: in vitro and in vivo analysis.
    Coll JL; Negoescu A; Louis N; Sachs L; Tenaud C; Girardot V; Demeinex B; Brambilla E; Brambilla C; Favrot M
    Hum Gene Ther; 1998 Sep; 9(14):2063-74. PubMed ID: 9759933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoparticle-mediated wild-type p53 gene delivery results in sustained antiproliferative activity in breast cancer cells.
    Prabha S; Labhasetwar V
    Mol Pharm; 2004; 1(3):211-9. PubMed ID: 15981924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.